ArticleOncotarget2018

SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia.

Jolanda Sarno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.